Using AI to understand the biological factors behind exceptional longevity.

AI-powered cross-level cross-species omics data integration to elucidate mechanisms of EL

NIH-funded research Hunter College · NIH-10729946

This study is exploring how certain biological factors work together to help people live longer, with the hope that what we learn can lead to better treatments for age-related diseases like Alzheimer's.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionHunter College NIH-funded
Lab location1 site (New York, United States)
Project IDNIH-10729946 on NIH RePORTER

What this research studies

This research aims to uncover the molecular mechanisms that contribute to exceptional longevity by integrating complex biological data from various sources. It employs advanced machine learning techniques to analyze multi-omics data, which includes genetic, RNA, protein, and metabolic information. By developing a deep learning framework, the project seeks to improve our understanding of how these molecular components interact and influence aging and longevity. Patients may benefit from insights gained that could lead to new therapeutic strategies for age-related diseases, particularly Alzheimer's.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals interested in the biological aspects of aging and those with a family history of exceptional longevity or Alzheimer's disease.

Not a fit: Patients with no interest in aging research or those who do not have a genetic predisposition to longevity or Alzheimer's may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to breakthroughs in understanding aging and developing treatments for age-related conditions like Alzheimer's disease.

How similar studies have performed: Other research has shown promise in using machine learning for biological data integration, but this specific approach to exceptional longevity is relatively novel.

Where this research is happening

New York, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.